Novartis AG and Amgen Inc. Take Aim at Johnson & Johnson
Novartis AG and Amgen Inc. have promising new psoriasis drugs that could challenge Johnson & Johnson's Stelara for market share.
Can These Top Dividend-Paying Stocks Soar in 2015?
There's more to top dividend-paying stocks than the yield.
Can Pfizer’s Cholesterol Drug Catch Up To The Competition?
Pfizer’s bococizumab remains in last place in the PCSK9 race. Will it arrive too late to make a meaningful impact on the market?